Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion

The partial remission (PR) phase of type 1 diabetes (T1D) is an underexplored period characterized by endogenous insulin production and downmodulated autoimmunity. To comprehend the mechanisms behind this transitory phase and develop precision medicine strategies, biomarker discovery and patient str...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Muñoz, Laia, Perna-Barrull, David, Murillo, Marta, Armengol, Maria Pilar, Alcalde, Marta, Catala, Marti, Rodriguez-Fernandez, Silvia, Sunye, Sergi, Valls, Aina, Perez, Jacobo, Corripio, Raquel, Vives-Pi, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037622/
https://www.ncbi.nlm.nih.gov/pubmed/36960962
http://dx.doi.org/10.3390/ncrna9020017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037622/
https://www.ncbi.nlm.nih.gov/pubmed/36960962
http://dx.doi.org/10.3390/ncrna9020017

Ejemplares similares